Ventyx Biosciences, Inc.
VTYX
$2.73
$0.0752.83%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 15.53% | 28.86% | 37.22% | 34.76% | 40.00% |
| Total Depreciation and Amortization | 2.22% | -12.75% | -21.84% | 16.60% | 127.34% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.87% | -23.77% | -21.83% | -51.64% | -43.76% |
| Change in Net Operating Assets | -47.81% | 85.18% | 129.12% | -125.41% | 363.22% |
| Cash from Operations | 13.29% | 46.00% | 54.99% | -2.30% | 50.21% |
| Capital Expenditure | 30.00% | 90.86% | 97.16% | 100.00% | 69.23% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 133.44% | -36.98% | -123.72% | -24.89% | -315.51% |
| Cash from Investing | 133.36% | -36.75% | -123.84% | -24.80% | -316.89% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -48.85% | -99.30% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 107.51% | -- | -104.27% | 1,553.05% | -136.64% |
| Foreign Exchange rate Adjustments | 2,788.89% | 2,480.00% | -170.93% | 1,100.00% | -123.68% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 104.18% | -99.10% | -585.85% | 255.15% | -744.82% |